Terug
77
Ook genoteerd als
AAVXF
OTC
Dagbereik
€ 109,08
€ 116,92
52-Weeksbereik
€ 4,77
€ 148,83
Volume
1.361.749
50D / 200D Gem.
€ 119,11
/
€ 87,46
Vorige Slotkoers
€ 115,42
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -41,0 | 0,3 |
| P/B | 178,0 | 2,9 |
| ROE % | -149,0 | 3,7 |
| Net Margin % | -1633,1 | 3,8 |
| Rev Growth 5Y % | 261,8 | 10,0 |
| D/E | 2,4 | 0,2 |
Koersdoel Analisten
Hold
€ 142,50
+29.3%
Low: € 110,00
High: € 176,00
Forward WPA
-€ 3,07
Omzet Sch.
3,8 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 4,96
€ 3,05 – € 6,87
|
1,5 B | 1 |
| FY2029 |
€ 5,35
€ 3,29 – € 7,41
|
1,2 B | 1 |
| FY2028 |
€ 0,71
€ 0,31 – € 1,11
|
570 M | 2 |
Belangrijkste Punten
Revenue grew 261,78% annually over 5 years — strong growth
Debt/Equity of 2,40 — high leverage
Negative free cash flow of -154,72M
PEG of 0,14 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 128,24%
Capital efficient — spends only 5,96% of revenue on capex
Groei
Revenue Growth (5Y)
261,78%
Revenue (1Y)133,54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-148,98%
ROIC-94,05%
Net Margin-1633,08%
Op. Margin-1602,89%
Veiligheid
Debt / Equity
2,40
Current Ratio1,84
Interest Coverage-41,33
Waardering
P/E Ratio
-40,99
P/B Ratio177,99
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 133,54% | Revenue Growth (3Y) | 53,45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 261,78% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 10,79M | Net Income (TTM) | -176,24M |
| ROE | -148,98% | ROA | -85,88% |
| Gross Margin | 100,00% | Operating Margin | -1602,89% |
| Net Margin | -1633,08% | Free Cash Flow (TTM) | -154,72M |
| ROIC | -94,05% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,40 | Current Ratio | 1,84 |
| Interest Coverage | -41,33 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -40,99 | P/B Ratio | 177,99 |
| P/S Ratio | 669,35 | PEG Ratio | 0,14 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 7,22B | Enterprise Value | 7,18B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 10,79M | 4,62M | 4,58M | 37.000,0 | 63.000,0 |
| Net Income | -176,24M | -147,74M | -60,74M | -42,45M | -37,55M |
| EPS (Diluted) | -2,80 | -3,43 | -3,18 | -2,75 | -2,62 |
| Gross Profit | 10,79M | 4,57M | 4,47M | -119.000,0 | -33,77M |
| Operating Income | -172,98M | -127,38M | -64,84M | -41,40M | -38,01M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 205,23M | 327,06M | 75,54M | 109,23M | 71,30M |
| Total Liabilities | 164,64M | 131,05M | 68,36M | 83,30M | 53,40M |
| Shareholders' Equity | 40,58M | 196,01M | 7,19M | 25,93M | 17,90M |
| Total Debt | 97,36M | 58,04M | 39,16M | 51,65M | 33,99M |
| Cash & Equivalents | 144,22M | 251,94M | 26,95M | 60,70M | 29,30M |
| Current Assets | 170,67M | 285,97M | 36,18M | 75,21M | 37,67M |
| Current Liabilities | 92,83M | 88,12M | 51,46M | 32,26M | 19,41M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#5 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026